-
1
-
-
79955918190
-
High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial
-
Schwartz G.G., Chaitman B.R., Goldberger J.J., et al. High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Am Heart J 2011, 161:993-999.
-
(2011)
Am Heart J
, vol.161
, pp. 993-999
-
-
Schwartz, G.G.1
Chaitman, B.R.2
Goldberger, J.J.3
-
2
-
-
42949123402
-
Dose-related effect of statins on atrial fibrillation after cardiac surgery
-
Kourliouros A., De Souza A., Roberts N., et al. Dose-related effect of statins on atrial fibrillation after cardiac surgery. Ann Thorac Surg 2008, 85:1515-1520.
-
(2008)
Ann Thorac Surg
, vol.85
, pp. 1515-1520
-
-
Kourliouros, A.1
De Souza, A.2
Roberts, N.3
-
3
-
-
71849109250
-
Atrial fibrillation at baseline and during follow-up in ALLHAT (antihypertensive and lipid-lowering treatment to prevent heart attack trial)
-
Haywood L.J., Ford C.E., Crow R.S., et al. Atrial fibrillation at baseline and during follow-up in ALLHAT (antihypertensive and lipid-lowering treatment to prevent heart attack trial). JAm Coll Cardiol 2009, 54:2023-2031.
-
(2009)
JAm Coll Cardiol
, vol.54
, pp. 2023-2031
-
-
Haywood, L.J.1
Ford, C.E.2
Crow, R.S.3
-
4
-
-
34447521792
-
Role of Rac1 GTPase activation in atrial fibrillation
-
Adam O., Frost G., Custodis F., et al. Role of Rac1 GTPase activation in atrial fibrillation. JAm Coll Cardiol 2007, 50:359-367.
-
(2007)
JAm Coll Cardiol
, vol.50
, pp. 359-367
-
-
Adam, O.1
Frost, G.2
Custodis, F.3
-
5
-
-
79952662118
-
Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk
-
Marinigh R., Lane D.A., Lip G.Y. Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk. JAm Coll Cardiol 2011, 57:1339-1348.
-
(2011)
JAm Coll Cardiol
, vol.57
, pp. 1339-1348
-
-
Marinigh, R.1
Lane, D.A.2
Lip, G.Y.3
-
6
-
-
78449259952
-
Dyslipidemia in chronic kidney disease: are statins still indicated in reduction cardiovascular risk in patients on dialysis treatmentα
-
Scarpioni R., Ricardi M., Melfa L., et al. Dyslipidemia in chronic kidney disease: are statins still indicated in reduction cardiovascular risk in patients on dialysis treatmentα. Cardiovasc Ther 2010, 28:361-368.
-
(2010)
Cardiovasc Ther
, vol.28
, pp. 361-368
-
-
Scarpioni, R.1
Ricardi, M.2
Melfa, L.3
-
7
-
-
35548999735
-
Statin use and recurrence of atrial fibrillation after successful cardioversion
-
Humphries K.H., Lee M., Sheldon R., et al. Statin use and recurrence of atrial fibrillation after successful cardioversion. Am Heart J 2007, 154:908-913.
-
(2007)
Am Heart J
, vol.154
, pp. 908-913
-
-
Humphries, K.H.1
Lee, M.2
Sheldon, R.3
-
8
-
-
36148959362
-
Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure
-
Adabag A.S., Nelson D.B., Bloomfield H.E. Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure. Am Heart J 2007, 154:1140-1145.
-
(2007)
Am Heart J
, vol.154
, pp. 1140-1145
-
-
Adabag, A.S.1
Nelson, D.B.2
Bloomfield, H.E.3
-
9
-
-
78650291503
-
Preoperative high-dose atorvastatin for prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial
-
Kourliouros A., Valencia O., Hosseini M.T., et al. Preoperative high-dose atorvastatin for prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JThorac Cardiovasc Surg 2011, 141:244-248.
-
(2011)
JThorac Cardiovasc Surg
, vol.141
, pp. 244-248
-
-
Kourliouros, A.1
Valencia, O.2
Hosseini, M.T.3
-
10
-
-
77953120103
-
Association between statin use and the incidence of atrial fibrillation following hospitalization for coronary artery disease
-
Kulik A., Singh J.P., Levin R., et al. Association between statin use and the incidence of atrial fibrillation following hospitalization for coronary artery disease. Am J Cardiol 2010, 105:1655-1660.
-
(2010)
Am J Cardiol
, vol.105
, pp. 1655-1660
-
-
Kulik, A.1
Singh, J.P.2
Levin, R.3
-
11
-
-
34548687059
-
Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery
-
Mariscalco G., Lorusso R., Klersy C., et al. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg 2007, 84:1158-1164.
-
(2007)
Ann Thorac Surg
, vol.84
, pp. 1158-1164
-
-
Mariscalco, G.1
Lorusso, R.2
Klersy, C.3
-
12
-
-
71149118928
-
Non-atheroprotective effects of statins: a systematic review
-
Beri A., Sural N., Mahajan S.B. Non-atheroprotective effects of statins: a systematic review. Am J Cardiovasc Drugs 2009, 9:361-370.
-
(2009)
Am J Cardiovasc Drugs
, vol.9
, pp. 361-370
-
-
Beri, A.1
Sural, N.2
Mahajan, S.B.3
-
13
-
-
84885306020
-
Dosage of statin, cardiovascular comorbidities, and risk of atrial fibrillation: a nationwide population-based cohort study
-
Hung C.Y., Lin C.H., Wang K.Y., et al. Dosage of statin, cardiovascular comorbidities, and risk of atrial fibrillation: a nationwide population-based cohort study. Int J Cardiol 2013, 168(2):1131-1136.
-
(2013)
Int J Cardiol
, vol.168
, Issue.2
, pp. 1131-1136
-
-
Hung, C.Y.1
Lin, C.H.2
Wang, K.Y.3
-
14
-
-
84872584350
-
CHADS(2) score, statin therapy, and risks of atrial fibrillation
-
Hung C.Y., Lin C.H., Loh el W., et al. CHADS(2) score, statin therapy, and risks of atrial fibrillation. Am J Med 2013, 126:133-140.
-
(2013)
Am J Med
, vol.126
, pp. 133-140
-
-
Hung, C.Y.1
Lin, C.H.2
Loh el, W.3
-
15
-
-
84929511055
-
Statin use and risk of atrial fibrillation or flutter: a population-based case-control study
-
Veronese G., Montomoli J., Schmidt M., et al. Statin use and risk of atrial fibrillation or flutter: a population-based case-control study. Am J Ther 2013, 10.1097/MJT.0b013e31827ab488.
-
(2013)
Am J Ther
-
-
Veronese, G.1
Montomoli, J.2
Schmidt, M.3
-
16
-
-
33750561096
-
Statins for treatment of dyslipidemia in chronic kidney disease
-
Shurraw S., Tonelli M. Statins for treatment of dyslipidemia in chronic kidney disease. Perit Dial Int 2006, 26:523-539.
-
(2006)
Perit Dial Int
, vol.26
, pp. 523-539
-
-
Shurraw, S.1
Tonelli, M.2
-
17
-
-
64249092502
-
Cardiovascular disease in patients with renal disease: the role of statins
-
Fellstrom B., Holdaas H., Jardine A.G., et al. Cardiovascular disease in patients with renal disease: the role of statins. Curr Med Res Opin 2009, 25:271-285.
-
(2009)
Curr Med Res Opin
, vol.25
, pp. 271-285
-
-
Fellstrom, B.1
Holdaas, H.2
Jardine, A.G.3
-
18
-
-
41549099286
-
Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering
-
Paraskevas K.I. Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering. Int Urol Nephrol 2008, 40:165-170.
-
(2008)
Int Urol Nephrol
, vol.40
, pp. 165-170
-
-
Paraskevas, K.I.1
-
19
-
-
79960133368
-
Sunrise of statins after AURORA and 4Dα
-
Wanner C., Krane V. Sunrise of statins after AURORA and 4Dα. JAm Soc Nephrol 2011, 22:1184-1186.
-
(2011)
JAm Soc Nephrol
, vol.22
, pp. 1184-1186
-
-
Wanner, C.1
Krane, V.2
-
20
-
-
22844435378
-
Identification of individuals with CKD from Medicare claims data: a validation study
-
Winkelmayer W.C., Schneeweiss S., Mogun H., et al. Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis 2005, 46:225-232.
-
(2005)
Am J Kidney Dis
, vol.46
, pp. 225-232
-
-
Winkelmayer, W.C.1
Schneeweiss, S.2
Mogun, H.3
-
21
-
-
54749114827
-
Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation-a nationwide descriptive study in Taiwan
-
Lin L.J., Cheng M.H., Lee C.H., et al. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation-a nationwide descriptive study in Taiwan. Clin Ther 2008, 30:1726-1736.
-
(2008)
Clin Ther
, vol.30
, pp. 1726-1736
-
-
Lin, L.J.1
Cheng, M.H.2
Lee, C.H.3
-
22
-
-
84857157135
-
High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial
-
Pena J.M., MacFadyen J., Glynn R.J., et al. High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial. Eur Heart J 2012, 33:531-537.
-
(2012)
Eur Heart J
, vol.33
, pp. 531-537
-
-
Pena, J.M.1
MacFadyen, J.2
Glynn, R.J.3
-
23
-
-
67649831565
-
Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causationα
-
Anselmi A., Possati G., Gaudino M. Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causationα. Ann Thorac Surg 2009, 88:326-333.
-
(2009)
Ann Thorac Surg
, vol.88
, pp. 326-333
-
-
Anselmi, A.1
Possati, G.2
Gaudino, M.3
-
25
-
-
54949113715
-
The impact of statin use on atrial fibrillation
-
Sanchez-Quinones J., Marin F., Roldan V., et al. The impact of statin use on atrial fibrillation. QJM 2008, 101:845-861.
-
(2008)
QJM
, vol.101
, pp. 845-861
-
-
Sanchez-Quinones, J.1
Marin, F.2
Roldan, V.3
-
26
-
-
84881309914
-
Discontinuation of statin therapy associates with Parkinson disease: a population-based study
-
Lee Y.C., Lin C.H., Wu R.M., et al. Discontinuation of statin therapy associates with Parkinson disease: a population-based study. Neurology 2013, 81:410-416.
-
(2013)
Neurology
, vol.81
, pp. 410-416
-
-
Lee, Y.C.1
Lin, C.H.2
Wu, R.M.3
-
27
-
-
84878791450
-
Statins of high versus low cholesterol-lowering efficacy and the development of severe renal failure
-
Chung Y.H., Lee Y.C., Chang C.H., et al. Statins of high versus low cholesterol-lowering efficacy and the development of severe renal failure. Pharmacoepidemiol Drug Saf 2013, 10.1002/pds.3433.
-
(2013)
Pharmacoepidemiol Drug Saf
-
-
Chung, Y.H.1
Lee, Y.C.2
Chang, C.H.3
-
28
-
-
77955485289
-
Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis
-
Chen W.T., Krishnan G.M., Sood N., et al. Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis. JThorac Cardiovasc Surg 2010, 140:364-372.
-
(2010)
JThorac Cardiovasc Surg
, vol.140
, pp. 364-372
-
-
Chen, W.T.1
Krishnan, G.M.2
Sood, N.3
-
29
-
-
78449237306
-
Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: data from the FAST-MI register
-
Danchin N., Fauchier L., Marijon E., et al. Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: data from the FAST-MI register. Heart 2010, 96:1809-1814.
-
(2010)
Heart
, vol.96
, pp. 1809-1814
-
-
Danchin, N.1
Fauchier, L.2
Marijon, E.3
-
30
-
-
80052602720
-
Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins
-
Reilly S.N., Jayaram R., Nahar K., et al. Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation 2011, 124:1107-1117.
-
(2011)
Circulation
, vol.124
, pp. 1107-1117
-
-
Reilly, S.N.1
Jayaram, R.2
Nahar, K.3
-
31
-
-
37549053629
-
Effect of statins on collagen type I degradation in patients with coronary artery disease and atrial fibrillation
-
Tziakas D.N., Chalikias G.K., Stakos D.A., et al. Effect of statins on collagen type I degradation in patients with coronary artery disease and atrial fibrillation. Am J Cardiol 2008, 101:199-202.
-
(2008)
Am J Cardiol
, vol.101
, pp. 199-202
-
-
Tziakas, D.N.1
Chalikias, G.K.2
Stakos, D.A.3
-
32
-
-
79959746706
-
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial
-
Baigent C., Landray M.J., Reith C., et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial. Lancet 2011, 377:2181-2192.
-
(2011)
Lancet
, vol.377
, pp. 2181-2192
-
-
Baigent, C.1
Landray, M.J.2
Reith, C.3
-
33
-
-
4644272251
-
Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics
-
Wanner C., Krane V., Marz W., et al. Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics. Kidney Blood Press Res 2004, 27:259-266.
-
(2004)
Kidney Blood Press Res
, vol.27
, pp. 259-266
-
-
Wanner, C.1
Krane, V.2
Marz, W.3
-
34
-
-
63849163945
-
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
-
Fellstrom B.C., Jardine A.G., Schmieder R.E., et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. NEngl J Med 2009, 360:1395-1407.
-
(2009)
NEngl J Med
, vol.360
, pp. 1395-1407
-
-
Fellstrom, B.C.1
Jardine, A.G.2
Schmieder, R.E.3
-
35
-
-
79960667212
-
The role of statins in chronic kidney disease
-
Kalaitzidis R.G., Elisaf M.S. The role of statins in chronic kidney disease. Am J Nephrol 2011, 34:195-202.
-
(2011)
Am J Nephrol
, vol.34
, pp. 195-202
-
-
Kalaitzidis, R.G.1
Elisaf, M.S.2
-
36
-
-
78650184434
-
Study of heart and renal protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
-
785-794 e710
-
Sharp Collaborative G. Study of heart and renal protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. Am Heart J 2010, 160. 785-794 e710.
-
(2010)
Am Heart J
, vol.160
-
-
Sharp Collaborative, G.1
-
37
-
-
79958107533
-
Statins and lipid-lowering strategies in cardiorenal patients
-
Bianchi S., Grimaldi D., Bigazzi R. Statins and lipid-lowering strategies in cardiorenal patients. Contrib Nephrol 2011, 171:143-150.
-
(2011)
Contrib Nephrol
, vol.171
, pp. 143-150
-
-
Bianchi, S.1
Grimaldi, D.2
Bigazzi, R.3
|